RetinalGenix Technologies (RetinalGenix Technologies) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RetinalGenix Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. RetinalGenix Technologies's Free Cash Flow for the three months ended in Mar. 2024 was $-0.14 Mil. RetinalGenix Technologies's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, RetinalGenix Technologies's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, RetinalGenix Technologies's current FCF Yield % is -0.66%.

The historical rank and industry rank for RetinalGenix Technologies's FCF Margin % or its related term are showing as below:

RTGN's FCF Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: -7.07
* Ranked among companies with meaningful FCF Margin % only.

RetinalGenix Technologies FCF Margin % Historical Data

The historical data trend for RetinalGenix Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RetinalGenix Technologies FCF Margin % Chart

RetinalGenix Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

RetinalGenix Technologies Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of RetinalGenix Technologies's FCF Margin %

For the Medical Devices subindustry, RetinalGenix Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RetinalGenix Technologies's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RetinalGenix Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where RetinalGenix Technologies's FCF Margin % falls into.

RetinalGenix Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

RetinalGenix Technologies's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.348	/	0
	=	%

RetinalGenix Technologies's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.143	/	0
	=	%

RetinalGenix Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of RetinalGenix Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

RetinalGenix Technologies (RetinalGenix Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RetinalGenix Technologies Inc (OTCPK:RTGN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1450 North McDowell Boulevard, Suite 150, Petaluma, CA, USA, 94954

Website

https://www.retinalgenix.com

RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.